Rebecca Kruse-Jarres

10PUBLICATIONS
27CO-AUTHORS
AutoimmunityHaematologyBehavioural epidemiologyMajor global burdens of diseaseCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 03, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.

Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski

|Sep 06, 2023
How I treat von Willebrand disorders in older adults.

Jacqueline N Poston, Rebecca Kruse-Jarres

|Aug 08, 2022
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies.

Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg

|Nov 20, 2020
Assessing patient and caregiver preferences for treatment of haemophilia A: A discrete choice experiment.

Melody Benton, Anisha M Patel, Lizheng Shi

|Apr 25, 2019
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS).

Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan

|Feb 07, 2019
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non-interventional study in a real-world setting.

Rebecca Kruse-Jarres, Johannes Oldenburg, Elena Santagostino

Pageof 2